Found: 16
Select item for more details and to access through your institution.
Caenorhabditis elegans ABL-1 antagonizes p53-mediated germline apoptosis after ionizing irradiation.
- Published in:
- Nature Genetics, 2004, v. 36, n. 8, p. 906, doi. 10.1038/ng1396
- By:
- Publication type:
- Article
Efficacy of HER2-Targeted Intraperitoneal <sup>225</sup>Ac α-Pretargeted Radioimmunotherapy for Small-Volume Ovarian Peritoneal Carcinomatosis.
- Published in:
- Journal of Nuclear Medicine, 2023, v. 64, n. 9, p. 1439, doi. 10.2967/jnumed.122.265095
- By:
- Publication type:
- Article
First-in-Human Trial of Dasatinib-Derivative Tracer for Tumor Kinase-Targeted Positron Emission Tomography.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 12, p. 1, doi. 10.2967/jnumed.119.234864
- By:
- Publication type:
- Article
First-in-Human Trial of Dasatinib-Derivative Tracer for Tumor Kinase-Targeted Positron Emission Tomography.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 11, p. 1, doi. 10.2967/jnumed.119.234864
- By:
- Publication type:
- Article
First-in-Human Trial of Dasatinib-Derivative Tracer for Tumor Kinase-Targeted Positron Emission Tomography.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 10, p. 1, doi. 10.2967/jnumed.119.234864
- By:
- Publication type:
- Article
First-in-Human Trial of Dasatinib-Derivative Tracer for Tumor Kinase-Targeted Positron Emission Tomography.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 9, p. 1, doi. 10.2967/jnumed.119.234864
- By:
- Publication type:
- Article
First-in-Human Trial of Dasatinib-Derivative Tracer for Tumor Kinase-Targeted Positron Emission Tomography.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 8, p. 1, doi. 10.2967/jnumed.119.234864
- By:
- Publication type:
- Article
First-in-Human Trial of Dasatinib-Derivative Tracer for Tumor Kinase-Targeted Positron Emission Tomography.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 7, p. 1, doi. 10.2967/jnumed.119.234864
- By:
- Publication type:
- Article
First-in-Human Trial of Dasatinib-Derivative Tracer for Tumor Kinase-Targeted Positron Emission Tomography.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 6, p. 1, doi. 10.2967/jnumed.119.234864
- By:
- Publication type:
- Article
First-in-Human Trial of Dasatinib-Derivative Tracer for Tumor Kinase-Targeted Positron Emission Tomography.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 5, p. 1, doi. 10.2967/jnumed.119.234864
- By:
- Publication type:
- Article
First-in-Human Trial of Dasatinib-Derivative Tracer for Tumor Kinase-Targeted Positron Emission Tomography.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 4, p. 1, doi. 10.2967/jnumed.119.234864
- By:
- Publication type:
- Article
Remodeling the Vascular Microenvironment of Glioblastoma with α-Particles.
- Published in:
- Journal of Nuclear Medicine, 2016, v. 57, n. 11, p. 1771, doi. 10.2967/jnumed.116.173559
- By:
- Publication type:
- Article
Evaluation of Castration-Resistant Prostate Cancer with Androgen Receptor-Axis Imaging.
- Published in:
- Journal of Nuclear Medicine, 2016, v. 57, p. 73S, doi. 10.2967/jnumed.115.170134
- By:
- Publication type:
- Article
<sup>124</sup>I-Iodopyridopyrimidinone for PET of Abl Kinase-Expressing Tumors In Vivo.
- Published in:
- Journal of Nuclear Medicine, 2010, v. 51, n. 1, p. 121, doi. 10.2967/jnumed.109.066126
- By:
- Publication type:
- Article
Feed-forward alpha particle radiotherapy ablates androgen receptor-addicted prostate cancer.
- Published in:
- Nature Communications, 2018, v. 9, n. 1, p. 1, doi. 10.1038/s41467-018-04107-w
- By:
- Publication type:
- Article
Engineering CAR-T cells for radiohapten capture in imaging and radioimmunotherapy applications.
- Published in:
- Theranostics, 2023, v. 13, n. 15, p. 5469, doi. 10.7150/thno.87489
- By:
- Publication type:
- Article